Philadelphia, Pennsylvania 19107

  • Diabetic Retinopathy

Purpose:

Comparing visual acuity measurements (measurements of how well you can see) using a standard ETDRS (Early Treatment Diabetic Retinopathy Study) chart and a handheld ETDRS chart


Study summary:

Prospective determination of agreement between standard ETDRS chart and handheld illuminated ETDRS equivalent chart in eyes with retinal pathology


Criteria:

Inclusion Criteria: 1. Ability to provide written informed consent and comply with study assessments for the full duration of the study (one visit per patient). 2. Age greater than 18 years. 3. Clinical diagnosis of retinal disease (including age-related macular degeneration, macular degeneration, retinal vessel occlusion, among others). Exclusion Criteria: 1. Presence of a significant cataract as determined by your doctor. 2. Presence of a significant posterior capsular opacity (haziness in your eyes) as determined by your doctor. 3. Diagnosis of uveitis (inflammation in part of the eye).


NCT ID:

NCT01622816


Primary Contact:

Principal Investigator
Julia Haller, MD
Wills Eye Institute


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.